The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells

Abstract Phosphoenolpyruvate carboxykinase (PEPCK) is a gluconeogenic enzyme with a cytosolic (Pck1/PEPCK-C) and mitochondrial (Pck2/PEPCK-M) isoform. Here we investigate the effect of 3-mercaptopicolinic acid (3-MPA), a PEPCK inhibitor, on C2C12 muscle cells. We report that Pck2 mRNA is 50–5000-fol...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Madelaine C. Brearley, Zoe C. T. R. Daniel, Paul T. Loughna, Tim Parr, John M. Brameld
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/700ab5aa868d43ae891ddb46d418f63a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:700ab5aa868d43ae891ddb46d418f63a
record_format	dspace
spelling	oai:doaj.org-article:700ab5aa868d43ae891ddb46d418f63a2021-12-02T13:34:01ZThe phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells10.1038/s41598-020-79324-92045-2322https://doaj.org/article/700ab5aa868d43ae891ddb46d418f63a2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79324-9https://doaj.org/toc/2045-2322Abstract Phosphoenolpyruvate carboxykinase (PEPCK) is a gluconeogenic enzyme with a cytosolic (Pck1/PEPCK-C) and mitochondrial (Pck2/PEPCK-M) isoform. Here we investigate the effect of 3-mercaptopicolinic acid (3-MPA), a PEPCK inhibitor, on C2C12 muscle cells. We report that Pck2 mRNA is 50–5000-fold higher than Pck1 during C2C12 myogenesis, indicating Pck2 is the predominant PEPCK isoform. C2C12 cell proliferation was inhibited in a dose-dependent manner following 48 h 3-MPA treatment (0.01–1 mM). C2C12 myogenic differentiation was significantly induced following 3-MPA treatment (0.25, 0.5, 1 mM) from day 0 of differentiation, demonstrated by increased creatine kinase activity, fusion index and myotube diameter; likewise, the myosin heavy chain (MyHC)-IIB isoform (encoded by Myh4) is an indicator of hypertrophy, and both porcine MYH4-promoter activity and endogenous Myh4 mRNA were also significantly induced. High doses (0.5 and/or 1 mM) of 3-MPA reduced mRNA expression of Pck2 and genes associated with serine biosynthesis (Phosphoglycerate dehydrogenase, Phgdh; phosphoserine aminotransferase-1, Psat1) following treatment from days 0 and 4. To conclude, as Pck2/PEPCK-M is the predominant isoform in C2C12 cells, we postulate that 3-MPA promoted myogenic differentiation through the inhibition of PEPCK-M. However, we were unable to confirm that 3-MPA inhibited PEPCK-M enzyme activity as 3-MPA interfered with the PEPCK enzyme assay, particularly at 0.5 and 1 mM.Madelaine C. BrearleyZoe C. T. R. DanielPaul T. LoughnaTim ParrJohn M. BrameldNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Madelaine C. Brearley Zoe C. T. R. Daniel Paul T. Loughna Tim Parr John M. Brameld The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells
description	Abstract Phosphoenolpyruvate carboxykinase (PEPCK) is a gluconeogenic enzyme with a cytosolic (Pck1/PEPCK-C) and mitochondrial (Pck2/PEPCK-M) isoform. Here we investigate the effect of 3-mercaptopicolinic acid (3-MPA), a PEPCK inhibitor, on C2C12 muscle cells. We report that Pck2 mRNA is 50–5000-fold higher than Pck1 during C2C12 myogenesis, indicating Pck2 is the predominant PEPCK isoform. C2C12 cell proliferation was inhibited in a dose-dependent manner following 48 h 3-MPA treatment (0.01–1 mM). C2C12 myogenic differentiation was significantly induced following 3-MPA treatment (0.25, 0.5, 1 mM) from day 0 of differentiation, demonstrated by increased creatine kinase activity, fusion index and myotube diameter; likewise, the myosin heavy chain (MyHC)-IIB isoform (encoded by Myh4) is an indicator of hypertrophy, and both porcine MYH4-promoter activity and endogenous Myh4 mRNA were also significantly induced. High doses (0.5 and/or 1 mM) of 3-MPA reduced mRNA expression of Pck2 and genes associated with serine biosynthesis (Phosphoglycerate dehydrogenase, Phgdh; phosphoserine aminotransferase-1, Psat1) following treatment from days 0 and 4. To conclude, as Pck2/PEPCK-M is the predominant isoform in C2C12 cells, we postulate that 3-MPA promoted myogenic differentiation through the inhibition of PEPCK-M. However, we were unable to confirm that 3-MPA inhibited PEPCK-M enzyme activity as 3-MPA interfered with the PEPCK enzyme assay, particularly at 0.5 and 1 mM.
format	article
author	Madelaine C. Brearley Zoe C. T. R. Daniel Paul T. Loughna Tim Parr John M. Brameld
author_facet	Madelaine C. Brearley Zoe C. T. R. Daniel Paul T. Loughna Tim Parr John M. Brameld
author_sort	Madelaine C. Brearley
title	The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells
title_short	The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells
title_full	The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells
title_fullStr	The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells
title_full_unstemmed	The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells
title_sort	phosphoenolpyruvate carboxykinase (pepck) inhibitor, 3-mercaptopicolinic acid (3-mpa), induces myogenic differentiation in c2c12 cells
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/700ab5aa868d43ae891ddb46d418f63a
work_keys_str_mv	AT madelainecbrearley thephosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT zoectrdaniel thephosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT paultloughna thephosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT timparr thephosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT johnmbrameld thephosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT madelainecbrearley phosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT zoectrdaniel phosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT paultloughna phosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT timparr phosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells AT johnmbrameld phosphoenolpyruvatecarboxykinasepepckinhibitor3mercaptopicolinicacid3mpainducesmyogenicdifferentiationinc2c12cells
_version_	1718392801302937600

The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells

Ejemplares similares